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A basis for accelerated progression of diabetic nephropathy in tions with type 2 diabetes is not observed. The Pima
Pima Indians. The Pima Indians of Arizona not only have a population is relatively small, so the incidence of less
much higher incidence of nephropathy due to type 2 diabetes common kidney diseases cannot be precisely determined,than Caucasians, but they also lose their renal function at an
although these diseases probably account for 5% ofaccelerated rate after they develop diabetic nephropathy. This
all ESRD among Pima Indians [3].rapid loss of renal function occurs despite a younger age of onset
of nephropathy and lower blood pressures and lipid levels, all The development and progression of diabetic nephrop-
of which would seem to predict a slower rate of progression athy—from the microalbuminuric incipient stage, through
of nephropathy. These findings suggest that other factors con- the macroalbuminuric overt stage on to ESRD—has beentribute to the rapid progression of renal disease in this popula-
studied in a large number of individuals using both func-tion. In particular, glomerulomegaly in this population may
tional and structural techniques [1, 4, 5]. In these sub-contribute to the high rate of glomerular filtration rate (GFR)
loss during the terminal, clinically manifest phase of nephropa- jects, the glomerular filtration rate (GFR) as determined
thy, because of the greater incremental loss of single-nephron by urinary iothalamate clearance has been measured se-
GFR (SNGFR) with each nephron lost to sclerosis. In nine
rially for periods of up to 10 years. In additional studies,Pima Indians with type 2 diabetic nephropathy who underwent
the physiologic and structural determinants of GFR alsorenal biopsy followed by serial iothalamate clearances for up
to ten years, we examined the relationship between glomerular were measured. A relative stability of GFR early on in
tuft volume at initial biopsy and the rate of GFR loss during subjects initially presenting with microalbuminuria has
the terminal phase. By multivariate analysis, significant inde- been demonstrated, while subjects with macroalbumin-
pendent effects of both glomerular volume (P  0.006) and
uria at the time of enrollment have been found to havepodocyte density (P 0.043) were evident in these individuals.
a much more rapid decline in their GFR (35%) over fiveThe effect of glomerular volume may result from a greater loss
of intrinsic filtration capacity with each glomerulus lost, while years of follow-up [2]. It is notable that the macroalbu-
the effect of podocyte density may reflect the destabilizing influ- minuric subjects had “normal” values of GFR at study
ence of “podocyte insufficiency” on the glomerular tuft. Similar entry (124 7 mL/min), comparable to Pima Indians withfactors may play a role in the rapid loss of GFR associated with
normal glucose tolerance. This apparent normality mustprogressive glomerular diseases in other indigenous populations
be interpreted critically, however, inasmuch as in the 1997in whom glomerulomegaly and glomerulopenia coexist.
study of Pagtalunan and colleagues, a macroalbuminuric
group of diabetic Pima Indians with only a slightly lower
GFR (103  12 mL/min) had an incidence of globalThe natural history and pathophysiology of diabetic
glomerular sclerosis that was much higher (19 4%) thannephropathy have been studied in Pima Indians for well
that in subjects with diabetes of short duration (3 1%)over a decade [1–4]. This population group has a very
[4]. This highlights the difficulty of assessing renal diseasehigh incidence of end-stage renal disease (ESRD), more
than 20 times that of the general US population, related progression during the clinically silent “pre-slippery slope”
to type 2 diabetes and diabetic nephropathy. Unlike Eu- phase. Physiologic, compensatory hyperfunction in the
ropean populations with type 2 diabetes and kidney dis- remnant nephrons can mask significant losses of intrinsic
ease, renal involvement occurs relatively early in life with filtration capacity, and thus obscure the initial structural
the Pima Indians and the significant incidence of non- phase of disease progression.
diabetic kidney disease seen in older European popula- The principal aim of this report is to address one spe-
cific question: Do the Pima Indians have a faster rate
of progression of renal disease in type 2 diabetes thanKey words: glomerulomegaly, glomerular filtration rate, indigenous
comparison non-indigenous populations and, if so, why?population, kidney disease, end-stage renal failure, progressive renal
disease, diabetes mellitus, This is different from the question of whether or not
there is a higher incidence of ESRD with type 2 diabetes 2003 by the International Society of Nephrology
S-38
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in this population: the answer to that question is easier. progressed to overt nephropathy (UAE 199 g/min),
whereas in our patient cohort about 10% of the 43 ini-There is about a 14-fold increased risk of ESRD in the
Pima Indian population. Understanding whether and tially microalbuminuric patients had undergone “final”
progression to macroalbuminuria [1]. Thus, with regardwhy the rate of progression to ESRD is faster in Pima
Indians may have significance in explaining the alarming to this aspect of their disease, the Pima population does
not seem to progress more rapidly, although the compari-epidemics of renal disease occurring in indigenous popu-
lations around the world, inasmuch as the Pima Indians son population in this case is notable for being hyperten-
sive.appear to share some characteristics with these other
population groups. Comparing rates of GFR loss between different popu-
lations is made difficult by the fact that quite different
methods of estimating GFR have been used in the vari-
REVIEW OF PERTINENT RESULTS
ous studies. Our cohorts of Pima Indians were studied
The question of whether Pima Indians with type 2 using urinary iothalamate clearances, while in other stud-
diabetic nephropathy have a faster rate of progression ies plasma clearances of ethylenediaminetetraacetic acid
of renal function is in fact ambiguous until the phrase (EDTA) [7] or iohexol, creatinine clearance or doubling
“rate of progression” is properly defined. The most un- of serum creatinine was used. In addition, it is important
ambiguous definition would probably be based on the to know from which starting point a loss of GFR is to
time from the onset of diabetes mellitus to the develop- be measured. Although the time of onset of diabetes is
ment of ESRD. Although this type of data is available a logical starting point, in most populations, type 2 diabe-
in the Pima Indian population, it is absent from the tes is discovered incidentally while investigating diabetic
traditional comparison population of Caucasian Europe- complications such as cardiovascular disease, making it
ans. Clearly, another approach to defining the rate of difficult to estimate the date of onset of diabetes. Unlike
progression is necessary. other populations, because of universal biennial screen-
This is made challenging by the fact that the concept ing, the actual time of onset of impaired glucose toler-
of progression is multifaceted, including both structural ance and diabetes in the Pima Indians is generally known
and functional aspects. Even accepting that “progression” to within about two years.
can mean variously development of irreversible struc- In the study of Nosadini et al, over a 3 year follow-
tural lesions, increases in urinary albumin excretion rates up period the average rate of loss of GFR in 34 macro-
or loss of GFR does not resolve the issue, as the latter albuminuric subjects (UAE 199 g/min) was 3 mL/min/
two physiologic variables are often quite non-monotonic. 1.73 m2 body surface area (BSA) per year, with half of
This is the result of the fact that they are the product of these patients manifesting a decrease in GFR and half
labile physiologic factors superimposed on more slowly not [7]. Among those whose disease progressed, the aver-
developing, largely irreversible structural lesions. Thus, age GFR loss was 11 mL/min/1.73 m2/year. In the study
patients may have urinary albumin excretion rates in of Christensen and colleagues of 34 macroalbuminuric
and out of the abnormal range for years before becoming type 2 diabetic patients with a median follow-up of 4 years,
persistently albuminuric. In our longitudinal study of the the mean rate of decrease in GFR was 5.3 mL/min/
development of overt nephropathy in initially micro- 1.73 m2 per year [8]. In our group of 34 Pima Indians
albuminuric Pima Indians [1], for example, there was a with type 2 diabetes and macroalbuminuria at enroll-
three to four year difference in the median time for ment, there was a mean rate of loss of absolute GFR of
progression from microalbuminuria to macroalbumin- 16 mL/min per year (unpublished data). Allowing for a
uria, depending upon whether this was defined as “first” median body surface area of 2.0, the average rate of
progression to macroalbuminuria [the first time a urinary GFR loss would be about 13.8 mL/min/1.73 m2 per year,
albumin/creatinine (A/C) ratio over 299 mg/g was found] over four times the rate of decline of the patients in
or “final” progression (the time from which all subse- Nosadini’s study and more than twice the rate of Chris-
quent A/C ratios were over 299 mg/g). tensen’s patients. In the study of Nosadini and col-
With respect to progression from microalbuminuria leagues, about 18% of the proteinuric patients had pro-
to macroalbuminuria, it is possible to compare this rate gressed to ESRD by the end of follow-up, while none
in Pima Indians with that in predominantly Caucasian were reported to have progressed to ESRD during fol-
hypertensive patients described in a recent study of Parv- low-up in Christensen’s group of patients. In our long-
ing et al [6]. The placebo group (N  201) in their term follow-up of Pima Indian subjects presenting with
treatment study started out with a urinary albumin excre- macroalbuminuria, on the other hand, the majority of
tion (UAE) rate of about 55 g/min, quite comparable the 35 subjects have progressed to ESRD by 10 years of
to our microalbuminuric group’s initial spot albumin/ follow-up.
creatinine (A/C) ratio of 81 mg/g [1]. At the end of 24 The development of glomerular sclerosis rarely has
been quantitatively studied. In Pima Indians there is amonths of follow-up, about 15% of their patients had
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trend for an increased frequency of sclerosis in subjects as that in controls calculated using the same model [12]:
15 versus 7 nL/min/mm Hg. With regard to the net intra-with more advanced stages of diabetic nephropathy [4].
In a longitudinal study of 12 Pima Indians initially pre- glomerular pressures sustaining ultrafiltration, both plasma
oncotic pressure and mean arterial pressure (as a surro-senting with microalbuminuria, there was a tendency (P
0.15) toward an increase in the incidence of global sclero- gate for intraglomerular hydrostatic pressure) are indis-
tinguishable in Pima Indians from healthy controls fromsis from 4% to 8% over four years of follow-up [5]. No
comparable studies are available in comparison popula- non-Indian populations, making a difference in the driv-
ing forces unlikely to lead to a significant difference intions of type 2 diabetics. The high degree of uncertainty
in determinations of the incidence of glomerular sclerosis the net ultrafiltration pressure. Although the situation
with respect to filtration pressure equilibrium is in gen-from biopsy specimens makes estimation of the rate of
development of global sclerosis problematic. This is com- eral not well understood in humans, the fact that non-
diabetic Pima Indians have the same filtration fractionpounded by the fact that sclerotic glomeruli are probably
eventually resorbed, so that this index of progression is (about 19%) as non-Pima subjects is consistent with their
being in the same state of filtration pressure equilibriumnot cumulative.
What are the factors that may account for a faster rate as the latter.
The preceding considerations suggest that normal glo-of functional progression in Pima Indians with type 2
diabetic nephropathy? As a first approach it is useful to merular number is low even in healthy, non-diabetic
Pima Indians, compared to Caucasian populations. Un-examine those characteristics in which Pima Indians dif-
fer from comparison populations. Any of the following der the assumption that the average GFR is constant
among all human populations (at least when normalizedmight be responsible for their propensity for more rapid
progression: increased glomerular size [4, 10], decreased for body size or lean body mass), a low glomerular num-
ber would be a virtual corollary of the existence of anglomerular epithelial cell density [4], early onset of dia-
betes, and poor glycemic control [1, 6, 7]. On the other elevated SNGFR. Given that the SNKf of Pima Indians
is twice that of comparison populations and that thehand, other factors exist that might be expected to miti-
gate the risk of rapid progression such as a lack of early driving forces for ultrafiltration are equal, the SNGFR
in the Pima group should be on average about twice thathypertension [1, 6, 7] and a lack of hyperlipidemia.
In the considerations that follow, only aspects of glo- of the comparison group, and the number of nephrons
in the former about half that in the comparison group.merular structure, including glomerular size and podo-
cyte number, will be addressed. Schmidt and colleagues We and others [10] have shown that in a number of
progressive glomerular diseases the best correlate forshowed some time ago that the mean glomerular volume
of both diabetic and non-diabetic Pima Indians under loss of GFR in the latter stages is the development of
global glomerular sclerosis. Assuming an equal rate of60 years of age (4.1  106 m3) was greater than that of
both whites (2.3  106 m3) and blacks (about 3.2  106 development of glomerular sclerosis, the increased sin-
gle-nephron GFR in Pima Indians implies that for eachm3) [9]. In the study of Pagtalunan et al, the average
glomerular volume in newly diagnosed diabetic Pima glomerulus lost a greater decrement in the overall GFR
would occur. In particular, once the slippery slope hasIndians with normal GFR was about twice that of the
predominantly Caucasian kidney transplant donors who been reached, the rate of functional loss in Pima Indians
(diabetic or not) would be about two times that of com-constituted the control population (5.4  106 m3 vs.
2.6  106 m3) [4]. parison populations for the same rate of glomerular loss.
This factor alone could account for much of the differ-Since the average GFR is not higher in non-diabetic
Pima Indians than in the comparison groups, it is likely ence in rates of GFR loss described above.
Little direct experimental data are available to addressthat either the single-nephron ultrafiltration coefficient
for the Pima population is unusually low for their large this possibility. We have made serial determinations of
GFR by iothalamate clearance, however, in a large cohortglomerular size; the net pressure for ultrafiltration is low;
or the single-nephron GFR is in fact elevated and the of Pima Indians with type 2 diabetes who were found to
have macroalbuminuria at screening. Ten of these subjectstotal number of nephrons is diminished. With regard to
the first possibility, Østerby and colleagues have shown had kidney biopsies performed at the beginning of their
follow-up [4]. Of these, nine had sufficiently linear GFRa strong relationship between filtration surface area and
GFR in patients with long-term type 1 diabetes with courses in their terminal phase to estimate rates of GFR
loss (Fig. 1). Over 79 to 129 months of follow-up, thesealbuminuria [10]. We have calculated an estimated sin-
gle-nephron ultrafiltration coefficient (SNKf) using the nine individuals lost GFR at a rate of about 18 mL/min/
year, quite similar to the 16 mL/min/year in the grouphydrodynamic model of Drumond and Deen [11] for
Pima Indians with early onset diabetes, normal renal of 34 subjects as a whole. ESRD occurred in seven of
the nine subjects during follow-up.function and normoalbuminuria [5]. The morphometri-
cally determined SNKf was approximately twice as great The relationship between the rate of GFR loss and
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Fig. 1. Course of glomerular filtration rate (GFR; iothalamate clear- Fig. 2. Relationship between rate of loss of GFR (mL/min/month) and
ance) over 80 months of follow-up in a Pima Indian with type 2 diabetes average glomerular volume (VG) determined from the biopsy at studyand macroalbuminuria at screening. The decline in the slope is linear. entry. The regression is significant (P  0.041).
Table 1. Multilinear regression model for rate of GFR lossglomerular tuft volume was examined by linear regres-
sion. There was a significantly greater rate of GFR loss Factor t value P value
with increasing glomerular volume (P  0.041; Fig. 2). Podocyte number
About half of the variation in the rate of GFR loss could VG 2.751 0.033
NP 2.634 0.039be explained by variation in glomerular volume (r2 
Podocyte density0.47). Because decreased podocyte density has been sug- VG 4.168 0.006
gested to contribute to the development of glomerular NV,podo 2.563 0.043
sclerosis [4, 13] and podocyte density would be expected Abbreviations are: VG, glomerular tuft volume; NP, absolute podocyte number/
glomerulus; NV,podo, podocyte density  podocytes/tuft volumeto decrease with increasing glomerular volume, it could
be argued that this relationship just represents the contri-
bution of glomerulomegaly to low podocyte densities.
Therefore, the relationship between the rate of GFR loss in comparison Caucasian populations. Glomerulomegaly
and several possible explanatory variables was examined (probably associated with inherited glomerulopenia)
by multilinear regression (stepwise procedure), with the could account for about a twofold greater rate of GFR
regression being performed on glomerular volume, ini- loss in the clinically overt stage of nephropathy simply
tial GFR, incidence of global sclerosis, and either podo- on the basis of a twofold greater loss of SNGFR with
cyte density or absolute podocyte number. If the effect each nephron lost to glomerular sclerosis. Since other
of increased glomerular volume on GFR loss were medi- indigenous populations also have been suggested to have
ated by decreases in podocyte density, the former vari- glomerulomegaly [14], it is possible that an increase in
able should fall out of the multivariate regression. In the terminal rate of GFR loss in these populations might
fact, glomerular volume remained the strongest factor in occur independently of any greater rate of loss of neph-
rons due to the disease process than in comparison popu-the model, whether podocyte number or podocyte density
lations.also was included. The t value for glomerular volume
Of course, glomerulomegaly could contribute also toactually increased with the addition of either of these
an increased rate of development of glomerular sclerosisvariables (Table 1), suggesting that glomerular volume
by virtue of leading to a decreased podocyte densityhas an independent impact on the rate of GFR loss.
within the glomerulus. Under conditions of podocyte
“sufficiency,” a greater glomerular volume (and ultrafil-
CONCLUSION tration capacity) in fact could be renoprotective, as glo-
The rate of loss of GFR in macroalbuminuric, type 2 merular hypertrophy may allow for adaptive rises in
SNGFR with lesser increases in intraglomerular capillarydiabetic Pima Indians appears to be greater than that
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